Enalapril and lisinopril in the treatment of mild to moderate essential hypertension

C. H. Espinel, J. L. Williams, Steven Scott Coughlin

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Hypertensive patients were randomly assigned to receive 5 mg of enalapril (n = 50) or 10 mg of lisinopril (n = 47) daily. During a four-week titration period, the doses were increased weekly to a maximum of 40 mg once daily until the treatment goal of diastolic blood pressure (BP) of < 90 mmHg was reached; treatment was then continued for four weeks. Systolic and diastolic BP declined significantly in the two treatment groups, from 147/98 mmHg in both the enalapril and lisinopril groups to 126/82 and 122/81 mmHg, respectively, at the end of treatment. During the first week of treatment, the goal of diastolic BP of < 90 mmHg was reached by 40% of the enalapril group and 62% of the lisinopril group; by the end of the titration period, 98% and 96%, respectively, had achieved the BP goal. Few side effects were reported and there were no abnormal laboratory findings during treatment. It is concluded that once-daily administration of enalapril or lisinopril was generally effective and well-tolerated in the management of mild to moderate uncomplicated essential hypertension.

Original languageEnglish (US)
Pages (from-to)181-190
Number of pages10
JournalClinical Therapeutics
Volume12
Issue number2
StatePublished - Jun 12 1990
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Enalapril and lisinopril in the treatment of mild to moderate essential hypertension'. Together they form a unique fingerprint.

  • Cite this